People

Damian Crowther

parkinsons.org.ukcic.vc

Dementia Discovery Fund venture partner and neurologist with academic and pharmaceutical research experience in protein aggregation and neurodegenerative disease. Damian Crowther is a published External Drug Discovery Adviser with the Parkinson’s Research Ventures programme. Own biography: Having trained in clinical neurology in Oxford, Nottingham and Cambridge, Damian then lead a neuroscience research group at the Cambridge Institute for Medical Research and Department of Genetics, University of Cambridge. Damian moved to industry in 2015, becoming the Director and Head of Early R&D with AstraZeneca Neuroscience.  He is Entrepreneur in Residence at Cambridge Innovation Capital and Venture Partner at SV’s Dementia Discovery Fund. The adviser/operating affiliation is distinct from a statutory directorship or personal cash check. Damian Crowther co-founded TRIMTECH and leads research. A neurologist and neuroscience entrepreneur, he previously led early discovery at AstraZeneca Neuroscience and conducted academic research at Cambridge. His entrepreneur-in-residence work includes DDF, CIC and Oxford Science Enterprises; he also co-founded GPnotebook. Damian Crowther is listed by Cambridge Innovation Capital as entrepreneur in residence. Life-sciences entrepreneur in residence with clinical neurobiology and early neuroscience drug-discovery experience, including AstraZeneca; existing TRIMTECH and other affiliations remain preserved. This affiliation follows CIC’s published directory; other career appointments are scoped to its biography and do not imply personal investment tickets.